Running Seahorse Assays on T Cells

Non-adherent, buffer-sensitive, and assayed in a medium they have never seen.

The three problems

ProblemConsequenceWorkaround
Non-adherent cellsCells settle and are disturbed by injectionCell-Tak, Matrigel, or a confluent feeder layer
Low cell number per wellSignal near noise; high variancePool wells; use the smallest plate format available
Assay buffer differs from culture mediumThe cell is measured after a medium switchPre-equilibrate ≥ 1 h; report the buffer composition

The third problem is the one that most changes interpretation. The assay buffer is bicarbonate-free so that pH can be measured, contains no serum, and is often glucose-limited. A cell measured 60 minutes after transfer to that buffer is a cell responding to transfer.

Cell number

Plate formatCells per wellNotes
96-well2–5 × 10⁵Typical for activated T cells
24-well5 × 10⁵ – 1 × 10⁶Lower variance; more material
384-well5 × 10⁴ – 1 × 10⁵Only for high-flux populations

Signal scales roughly with cell number, but not linearly at high density because of local nutrient depletion in a non-perfused well. Two densities should be run when a condition is new, and the linear range documented.

Readout note. Report OCR and ECAR per cell, using a terminal count of the same well (CyQUANT, or nuclei counting). Protein normalisation is unreliable for T cells: activation changes protein content per cell by several fold, so a per-microgram value can move in the opposite direction to a per-cell value.

Immobilisation

MethodMechanismEffect on the measurement
Cell-TakAdhesive protein coatingMinimal metabolic effect; requires careful coating consistency
Matrigel or poly-D-lysineMatrix coatingIntegrin signalling can alter activation state
Feeder monolayerAdherence by proxyFeeder cells contribute to the signal
None (settling)GravityInjection disturbs the cells; high variance

Caveat on coatings. Integrin engagement is not metabolically inert. A T cell adhering to a matrix is receiving a costimulatory-like signal, and the measured flux includes that. Where the comparison is between activation states, a constant coating is a controlled variable; where the comparison is with a suspension measurement, it is not.

Assay medium

ComponentStandard choiceWhy
BaseSeahorse XF base medium, or DMEM without bicarbonatepH measurement requires low buffering
GlucoseMatch the culture concentration, then test a lower one11 mM versus 5 mM changes the baseline
Glutamine1–2 mMSubstrate for the alternative route
PyruvateOptional; state whether presentFeeds the alternative route
SerumAbsentRequired for pH stability, but changes lipid availability
Phenol redAbsentOptical and pH interference
Equilibration1 h at 37 °C, no CO₂Removes residual bicarbonate

Two arms are worth running: one at the culture glucose concentration, one at a physiological concentration. If the phenotype is present at both, it is a property of the cell; if only at 11 mM, it is a property of the surplus.

Timing relative to activation

Day after activationStateInterpretation
0–1Early activation; flux risingCaptures the induction, not the programme
2–3Peak effector expansionThe usual window
5–7Contraction; some deathMixed live and dying cells; normalise carefully
10+Memory or exhaustion depending on protocolDifferent programme, different substrate

A "T cell metabolism" result without the day is not interpretable, because glycolytic flux changes several fold across the trajectory.

Important distinction. The comparison that matters is within the same day. Effector day 3 versus memory day 14 confounds the differentiation state with time in culture, cell density and medium exhaustion.

The derived parameters, and their assumptions

ParameterCalculationAssumption
Basal respirationPre-injection OCR − non-mitochondrialNon-mitochondrial rate is stable
ATP-linkedBasal − oligomycin OCROligomycin fully blocks ATP synthase
MaximalFCCP peak − non-mitochondrialFCCP concentration was titrated
Spare capacityMaximal − basalThe cell can use it
Proton leakOligomycin OCR − non-mitochondrialNot an artefact of oligomycin toxicity
GlycolysisECAR after glucoseAcidification is glycolytic
Glycolytic capacityECAR after oligomycinRespiratory CO₂ contribution is negligible

Caveat on FCCP. Uncorrected FCCP concentration produces a value that is neither maximal nor interpretable. A titration curve on the same cell type and day is required; the optimum differs between T cell states.

When SCENITH is the better choice

SCENITH measures substrate dependence per cell by flow cytometry, using translation rate as the readout under selective inhibitors.

SituationSeahorseSCENITH
Heterogeneous populationPopulation averagePer-cell distribution
Very few cellsSignal-limitedFeasible
Need for sorting or phenotypingNot compatibleCompatible
Absolute fluxReports ratesReports relative dependence

For a population with a bimodal response — which activated T cells frequently are — the per-cell method answers the question the population average hides.

Failures that recur

  • • ECAR reported as glycolytic rate without checking the respiratory contribution.
  • • Protein normalisation. Activation changes protein per cell.
  • • No terminal cell count, so well-to-well variation is unattributed.
  • • Assay buffer glucose unstated. The baseline is set by it.
  • • Day after activation unstated.
  • • FCCP not titrated for that cell state.
  • • Dying cells included at day 6–7, lowering the apparent flux of the population.

Where this connects

  • • Immunometabolism article supplies the trajectory and the claim-level distinctions this protocol serves.
  • • Glucose pillar supplies the ECAR interpretation rules.
  • • Mitochondrial pillar supplies the Mito Stress Test assumptions, which apply here with the additional problem of non-adherence.

Scientific interpretation and experimental design

  • • Report the buffer. Flux is measured in an artificial medium.
  • • Normalise per cell, terminally counted.
  • • State the day after activation.
  • • Titrate FCCP for the cell state.
  • • Run two glucose concentrations when the phenotype could be substrate-driven.
  • • Use SCENITH for heterogeneity.
  • • Exclude dying cells, or report them separately.

Selected references for further reading

  • • Argüello RJ, et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metabolism. 2020;32:1063–1075.
  • • Mookerjee SA, Gerencser AA, Nicholls DG, Brand MD. Quantifying intracellular rates of glycolytic and oxidative ATP production. Journal of Biological Chemistry. 2017;292:7189–7207.
  • • Divakaruni AS, Jastroch M. A practical guide for the analysis, standardization and interpretation of oxygen consumption measurements. Nature Metabolism. 2022;4:978–994.
  • • Buck MD, et al. Metabolic instruction of immunity. Cell. 2017;169:570–586.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: